Analyst Stance On Two Stocks: Mylan NV (MYL), Flexion Therapeutics, Inc. (FLXN)

Share

Mylan N.V.'s quarterly revenue was up 15.7% compared to the same quarter previous year. Deerfield Management Company who had been investing in Mylan N V for a number of months, seems to be bullish on the $20.35 billion market cap company. The share price has moved forward from its 20 days moving average, trading at a distance of 12.13% and stays 16.9% away from its 50 days moving average. Ubiquitech Software Corp (OTCMKTS:UBQU) has 0.00% since October 16, 2016 and is. Utah Retirement Systems acquired 14,000 shares as Mylan N V (MYL)'s stock declined 9.77%. BlackRock Inc. now owns 40,574,158 shares of the company's stock valued at $1,575,089,000 after buying an additional 1,751,515 shares during the last quarter. It is positive, as 23 investors sold CPRT shares while 8 reduced holdings. According to these analysts, the Low Revenue Estimate for Mylan N.V.is 3 Billion and the High Revenue Estimate is 3.21 Billion.

Wells Fargo & Company set a $32.00 price objective on Mylan (NASDAQ:MYL) in a research report report published on Wednesday, October 4th. It has underperformed by 24.43% the S&P500. We have $3.83 PT which if reached, will make NASDAQ:FLGT worth $3.57M less. It also reduced its holding in Galapagos Nv by 72,267 shares in the quarter, leaving it with 187,501 shares, and cut its stake in Recro Pharma Inc (NASDAQ:REPH). During the last 52 weeks, the price has been as high as $54.18 and as low as $42.56. During the same quarter in the previous year, the firm earned $1.16 EPS.

Investors sentiment is 1.33 in Q2 2017. Its the same as in 2017Q1.

United Services Automobile Association decreased its stake in Mylan (NASDAQ:MYL) by 2.6% during the first quarter, Holdings Channel reports. The company reported the earnings of $1.1/Share in the last quarter where the estimated EPS by analysts was $1.16/share. (NASDAQ:CPRT). Mutual Of America Capital Mgmt Ltd Limited Liability Company holds 0.09% or 166,626 shares in its portfolio. 223.17 million shares or 0.94% less from 225.30 million shares in 2017Q1 were reported. Dai Ichi Life Insurance Company Ltd raised its position in Mylan N.V.by 0.4% during the 2nd quarter. Adirondack Research & Mngmt holds 6,950 shares or 0.15% of its portfolio. The firm has "Overweight" rating given on Wednesday, November 18 by JP Morgan. Bloomberg.com's article titled: "Mylan Soars as Drug Approval Deals Blow to Teva Blockbuster" and published on October 04, 2017 is yet another important article.

Stock market analysts and brokers have recently amended their target prices on shares of Mylan Inc.

Among 16 analysts covering Trimble Navigation Limited (NASDAQ:TRMB), 8 have Buy rating, 0 Sell and 8 Hold. Therefore 85% are positive. Royal Bank Of Canada set a $41.00 target price on Mylan N.V. and gave the stock a "hold" rating in a research report on Sunday, July 16th. ValuEngine upgraded shares of Mylan from a hold rating to a buy rating in a research note on Monday, October 2nd. Nelson Roberts Invest Advsr holds 0.01% in Mylan N.V. (NASDAQ:MYL) or 300 shares. The stock of Mylan N.V. (NASDAQ:MYL) earned "Buy" rating by Deutsche Bank on Tuesday, July 28. The company was maintained on Tuesday, June 13 by Oppenheimer. The company now has an average rating of Buy and an average price target of $41.21. Morgan Stanley maintained Mylan N.V. (NASDAQ:MYL) on Friday, October 6 with "Equal-Weight" rating. Mizuho initiated it with "Buy" rating and $49 target in Wednesday, October 26 report. Vanguard Group Inc. raised its position in shares of Mylan by 12.0% during the second quarter. Mizuho has "Buy" rating and $5300 target. Goldman Sachs Grp Inc reported 0% of its portfolio in SM Energy Co (NYSE:SM).

08/09/2017 - Mylan Inc. had its "sector perform" rating reiterated by analysts at RBC Capital. (NASDAQ:QCOM) on Friday, September 29 with "Hold" rating. The stock of Mylan N.V. (NASDAQ:MYL) earned "Market Perform" rating by Cowen & Co on Monday, July 27. As per Wednesday, August 19, the company rating was maintained by BTIG Research. (NASDAQ:QCOM), 13 have Buy rating, 1 Sell and 21 Hold. (NASDAQ:QCOM) to report earnings on November, 1 after the close. (NYSE:CHD) earnings have risen with a quarterly rate of 4.9% over the last 5 years. QCOM's profit will be $1.02 billion for 19.14 P/E if the $0.69 EPS becomes a reality.

The analysts offering 12 month price targets for Mylan N.V. have a median target of $43, with a high estimate of $50 and a low estimate of $32. Vantage Investment Advisors Ltd Co owns 712 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Share